Low-gainer diet-induced obese microbiota transplanted mice exhibit increased fighting

IF 3.1 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Caroline M. Junker Mentzel, Yan Hui, Tanja Maria Stentoft Hammerich, Malene Klug-Dambmann, Yi Liu, Line Fisker Zachariassen, Lars Hestbjerg Hansen, Antonios Aslampaloglou, Maria Kiersgaard, Dennis Sandris Nielsen, Axel Kornerup Hansen, Lukasz Krych
{"title":"Low-gainer diet-induced obese microbiota transplanted mice exhibit increased fighting","authors":"Caroline M. Junker Mentzel,&nbsp;Yan Hui,&nbsp;Tanja Maria Stentoft Hammerich,&nbsp;Malene Klug-Dambmann,&nbsp;Yi Liu,&nbsp;Line Fisker Zachariassen,&nbsp;Lars Hestbjerg Hansen,&nbsp;Antonios Aslampaloglou,&nbsp;Maria Kiersgaard,&nbsp;Dennis Sandris Nielsen,&nbsp;Axel Kornerup Hansen,&nbsp;Lukasz Krych","doi":"10.1111/cts.13906","DOIUrl":null,"url":null,"abstract":"<p>Weight gain variation is a great challenge in diet-induced obesity studies since low-gainer animals are of limited experimental value. The inbred C57BL/6 (B6) mice are frequently used models due to their genetic homogeneity and susceptibility to diet-induced obesity (DIO). The aim of this study is to investigate if the gut microbiota (GM) influences the fraction of low weight gainers in DIO studies. A total of 100 male B6 mice (donor population) were fed a high-fat diet for 14 weeks and divided into the study groups high gainer (HG) and low gainer (LG) based on their weight gain. Subsequently, fecal matter transplantation (FMT) was done on germ-free B6 mice with GM from HG and LG donors (FMT population). LG (13.35 ± 2.5 g) and HG (25.52 ± 2.0 g) animals were identified by the weight gain from week 1 to week 12. Interestingly, the start weight of the LG (20.36 ± 1.4 g) and HG (21.59 ± 0.7 g) groups differed significantly. Transplanting LG or HG fecal matter to germ-free mice resulted in significant differences in weight gain between HG and LG, as well as differences in serum leptin levels and epididymal fat pad weight. A clear LG-specific GM composition could not be distinguished by 16S rRNA gene amplicon sequencing. Surprisingly, significantly more fighting was recorded in LG groups of both donor populations and when transplanted to germ-free mice. The HG and LG phenotypes could be transferred to germ-free mice. The increased fighting in the LG group in both studies suggests not only that the tendency to fight can be transferred by FMT in these mice, but also that fighting should be prevented in DIO studies to minimize the number of LG animals.</p>","PeriodicalId":50610,"journal":{"name":"Cts-Clinical and Translational Science","volume":"17 9","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cts.13906","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cts-Clinical and Translational Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cts.13906","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Weight gain variation is a great challenge in diet-induced obesity studies since low-gainer animals are of limited experimental value. The inbred C57BL/6 (B6) mice are frequently used models due to their genetic homogeneity and susceptibility to diet-induced obesity (DIO). The aim of this study is to investigate if the gut microbiota (GM) influences the fraction of low weight gainers in DIO studies. A total of 100 male B6 mice (donor population) were fed a high-fat diet for 14 weeks and divided into the study groups high gainer (HG) and low gainer (LG) based on their weight gain. Subsequently, fecal matter transplantation (FMT) was done on germ-free B6 mice with GM from HG and LG donors (FMT population). LG (13.35 ± 2.5 g) and HG (25.52 ± 2.0 g) animals were identified by the weight gain from week 1 to week 12. Interestingly, the start weight of the LG (20.36 ± 1.4 g) and HG (21.59 ± 0.7 g) groups differed significantly. Transplanting LG or HG fecal matter to germ-free mice resulted in significant differences in weight gain between HG and LG, as well as differences in serum leptin levels and epididymal fat pad weight. A clear LG-specific GM composition could not be distinguished by 16S rRNA gene amplicon sequencing. Surprisingly, significantly more fighting was recorded in LG groups of both donor populations and when transplanted to germ-free mice. The HG and LG phenotypes could be transferred to germ-free mice. The increased fighting in the LG group in both studies suggests not only that the tendency to fight can be transferred by FMT in these mice, but also that fighting should be prevented in DIO studies to minimize the number of LG animals.

Abstract Image

低体重饮食诱导的肥胖微生物群移植小鼠表现出更强的战斗力
由于低增重动物的实验价值有限,因此增重变化是饮食诱导肥胖研究中的一大挑战。近交系 C57BL/6(B6)小鼠因其遗传同质性和对饮食诱导肥胖(DIO)的易感性而成为常用的模型。本研究的目的是调查肠道微生物群(GM)是否会影响 DIO 研究中体重增加较低的小鼠的比例。研究人员给 100 只雄性 B6 小鼠(供体群体)喂食高脂肪食物 14 周,并根据其体重增加情况将其分为高增重组(HG)和低增重组(LG)。随后,用来自 HG 和 LG 供体(FMT 群体)的基因改造物对无菌 B6 小鼠进行了粪便物质移植(FMT)。LG(13.35 ± 2.5 g)和HG(25.52 ± 2.0 g)动物是根据第1周至第12周的体重增加情况确定的。有趣的是,LG 组(20.36 ± 1.4 g)和 HG 组(21.59 ± 0.7 g)的起始体重差异显著。将 LG 或 HG 粪便移植到无菌小鼠体内会导致 HG 和 LG 之间体重增加的显著差异,以及血清瘦素水平和附睾脂肪垫重量的差异。16S rRNA基因扩增片段测序无法区分出明显的LG特异性基因改造成分。令人惊讶的是,在两个供体群体的LG组中,以及在移植到无菌小鼠体内时,都记录到了明显更多的搏斗。HG和LG表型可以转移到无菌小鼠身上。在这两项研究中,LG 组打斗现象的增加不仅表明打斗倾向可通过 FMT 转移给这些小鼠,而且表明在 DIO 研究中应防止打斗,以尽量减少 LG 动物的数量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cts-Clinical and Translational Science
Cts-Clinical and Translational Science 医学-医学:研究与实验
CiteScore
6.70
自引率
2.60%
发文量
234
审稿时长
6-12 weeks
期刊介绍: Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信